Biodistribution and radiation dosimetry of the novel 18F-labeled prostate-specific membrane antigen-ligand PSMA-7 for PET/CT in prostate cancer patients

被引：0

作者：

Hohberg, Melanie ^{[4
]}

Dietlein, Markus ^{[4
]}

Kobe, Carsten ^{[4
]}

Dietlein, Felix ^{[1
]}

Zlatopolskiy, Boris ^{[3
]}

Krapf, Philipp ^{[2
]}

Wild, Markus ^{[4
]}

Taeger, Philipp ^{[4
]}

Neumaier, Bernd ^{[2
]}

Drzezga, Alexander ^{[4
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA USA

[2] Forschungszentrum Julich, Julich, Germany

[3] IREMB, Cologne, Germany

[4] Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany

来源：

JOURNAL OF NUCLEAR MEDICINE | 2018年 / 59卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页数：1

共 50 条

[21] Biodistribution and Radiation Dosimetry for a Probe Targeting Prostate-Specific Membrane Antigen for Imaging and Therapy
Herrmann, Ken
Bluemel, Christina
Weineisen, Martina
Schottelius, Margret
Wester, Hans-Juergen
Czernin, Johannes
Eberlein, Uta
Beykan, Seval
Lapa, Constantin
Riedmiller, Hubertus
Krebs, Markus
Kropf, Saskia
Schirbel, Andreas
Buck, Andreas K.
Lassmann, Michael
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (06) : 855 - 861
[22] Prostate-specific membrane antigen (PSMA) fusion imaging in prostate cancer: PET-CT vs PET-MRI
Liu, Feng-Yuan
Sheng, Ting-Wen
Tseng, Jing-Ren
Yu, Kai-Jie
Tsui, Ke-Hong
Pang, Se-Tong
Wang, Li-Jen
Lin, Gigin
BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1131):
[23] The Role of Prostate Specific Membrane Antigen (PSMA) PET/CT in the Clinical Management of Patients with Prostate Cancer
Davidson, Tima
Goldstein, Jeffrey
Hahiashvili, Maia
Goshen, Elinor
Oksman, Yakov
Berger, Raanan
Saad, Akram
Amit, Uri
Chikman, Bar
Symon, Zvi
Ben-Haim, Simona
JOURNAL OF NUCLEAR MEDICINE, 2016, 57
[24] The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels
Kabasakal, Levent
Demirci, Emre
Nematyazar, Jamal
Akyel, Resit
Razavi, Baresh
Ocak, Meltem
Aygun, Aslan
Obek, Can
Kural, Ali R.
NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (02) : 149 - 155
[25] The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients
Guler, O. C.
Engels, B.
Onal, C.
Everaert, H.
Van den Begin, R.
Gevaert, T.
de Ridder, M.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (04): : 484 - 490
[26] The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients
O. C. Guler
B. Engels
C. Onal
H. Everaert
R. Van den Begin
T. Gevaert
M. de Ridder
Clinical and Translational Oncology, 2018, 20 : 484 - 490
[27] Prostate-specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma
Mackay, Stephen
Oduor, Ian O.
Burch, Tanya C.
Troyer, Dean A.
Semmes, Oliver J.
Nyalwidhe, Julius O.
PROSTATE, 2024, 84 (05): : 479 - 490
[28] First-in-human phase 1 PET study of CTT1057, a novel 18F-labeled imaging agent targeting prostate specific membrane antigen (PSMA) in prostate cancer.
Aggarwal, Rahul Raj
Behr, Spencer
Seo, Youngho
Gao, Kenneth
Rahanfar, Vahid
Slater, Jim
Blecha, Joseph
Langton-Webster, Beatrice
Berkman, Clifford
Vanbrocklin, Henry
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[29] 99mTc-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer
Ray, Sangeeta
Pullambhatla, Mrudula
Falk, Alexander
Byun, Youngjoo
Foss, Catherine
Nimmagadda, Sridhar
Fox, James
Mease, Ronnie
Pomper, Martin
JOURNAL OF NUCLEAR MEDICINE, 2011, 52
[30] 68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
Banerjee, Sangeeta Ray
Pullambhatla, Mrudula
Byun, Youngjoo
Nimmagadda, Sridhar
Green, Gilbert
Fox, James J.
Horti, Andrew
Mease, Ronnie C.
Pomper, Martin G.
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (14) : 5333 - 5341

← 1 2 3 4 5 →